Johnson & Johnson (J&J) subsidiary Janssen Pharmaceutical has partnered with the Beth Israel Deaconess Medical Center (BIDMC) to advance Covid-19 vaccine development. The partners started preclinical testing of different vaccine prospects. The aim is to select a vaccine candidate for clinical trials by the end of this month. Janssen […]
Click here to view original web page at www.pharmaceutical-technology.com
